@article {1032, title = {Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.}, journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, volume = {47}, year = {2008}, month = {2008 Oct 1}, pages = {952-61}, abstract = {More than one-third of people in the United States with hepatic C virus (HCV) infection pass through the correctional system annually. Data are lacking on outcomes of treatment with pegylated interferon plus ribavirin (PEG-RBV) in correctional settings.}, keywords = {Adult, Antiviral Agents, Drug Therapy, Combination, Female, Hepatitis C, Humans, Interferon-alpha, Longitudinal Studies, Male, Middle Aged, Polyethylene Glycols, Prisoners, Prisons, Recombinant Proteins, Retrospective Studies, Ribavirin}, issn = {1537-6591}, doi = {10.1086/591707}, author = {Maru, Duncan Smith-Rohrberg and Bruce, Robert Douglas and Basu, Sanjay and Altice, Frederick L} }